These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 5125988
1. [Fluctuations of portal pressure under normal conditions and evaluation of the severity of portal hypertension in liver cirrhosis]. Mansurov KhKh. Ter Arkh; 1971 Jul; 43(6):65-9. PubMed ID: 5125988 [No Abstract] [Full Text] [Related]
2. [Portal hypertension in the absence of liver cirrhosis and extrahepatic circulatory blockade]. Bykov VS. Klin Med (Mosk); 1981 Oct; 59(10):22-6. PubMed ID: 7031355 [No Abstract] [Full Text] [Related]
6. [Spironolactone in the treatment of portal hypertension in liver cirrhosis. A new therapeutic principle?]. Klein CP. Dtsch Med Wochenschr; 1985 Nov 15; 110(46):1774-6. PubMed ID: 4054003 [Abstract] [Full Text] [Related]
7. [Mechanism of development of portal hypertension in liver cirrhosis]. Kalashnikov SA. Klin Med (Mosk); 1975 Apr 15; 53(4):74-8. PubMed ID: 1152376 [No Abstract] [Full Text] [Related]
8. [Estimation of portal pressure in cirrhotic patients by biochemical parameters: study of multiple correlations]. González Reimers CE, Santolaria Fernández F, Jorge Hernández JA, Batista López N, de Armas Trujillo D, Hernández Nieto L. Med Clin (Barc); 1982 Oct 15; 79(6):264-7. PubMed ID: 7144313 [No Abstract] [Full Text] [Related]
17. [Clinical approach to portal hypertension]. González Galilea A, Fraga Rivas E, Miño Fugarolas G. An Med Interna; 2000 Sep 15; 17(9):496-503. PubMed ID: 11100539 [Abstract] [Full Text] [Related]
19. Mechanism of action of isosorbide-5-mononitrate in reducing portal pressure in cirrhotic patients with cirrhosis and portal hypertension. Jenkins SA, Shields R. J Gastroenterol Hepatol; 1991 Sep 15; 6(1):91-3. PubMed ID: 1883984 [No Abstract] [Full Text] [Related]